S. Pay

638 total citations
21 papers, 443 citations indexed

About

S. Pay is a scholar working on Ophthalmology, Rheumatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, S. Pay has authored 21 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Ophthalmology, 9 papers in Rheumatology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in S. Pay's work include Ocular Diseases and Behçet’s Syndrome (9 papers), Systemic Lupus Erythematosus Research (6 papers) and Inflammasome and immune disorders (4 papers). S. Pay is often cited by papers focused on Ocular Diseases and Behçet’s Syndrome (9 papers), Systemic Lupus Erythematosus Research (6 papers) and Inflammasome and immune disorders (4 papers). S. Pay collaborates with scholars based in Türkiye, United States and Serbia. S. Pay's co-authors include A Dinç, Hakan Erdem, Güngör Sobacı, İsmail Şimşek, Hatice Rana Erdem, A. Şengül, Uğur Muşabak, Meral Çalgünerı, İhsan Ertenli and Mustafa Arıcı and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Clinical & Experimental Immunology.

In The Last Decade

S. Pay

21 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Pay Türkiye 12 174 170 159 116 74 21 443
Hidetoshi Kaneoka Japan 13 172 1.0× 203 1.2× 146 0.9× 81 0.7× 52 0.7× 22 478
Kamel Hamzaoui Tunisia 14 76 0.4× 202 1.2× 281 1.8× 110 0.9× 109 1.5× 34 506
A Dinç Türkiye 13 73 0.4× 184 1.1× 186 1.2× 51 0.4× 76 1.0× 20 400
H. Serhat Inaloz Türkiye 12 106 0.6× 218 1.3× 226 1.4× 72 0.6× 65 0.9× 27 534
Rosanna Dammacco Italy 8 75 0.4× 243 1.4× 284 1.8× 63 0.5× 106 1.4× 19 454
Saeedeh Shenavandeh Iran 10 50 0.3× 129 0.8× 104 0.7× 62 0.5× 66 0.9× 43 345
Peter Y. Chang United States 11 47 0.3× 168 1.0× 275 1.7× 38 0.3× 50 0.7× 33 479
Pınar Aydin Türkiye 14 54 0.3× 119 0.7× 325 2.0× 26 0.2× 50 0.7× 39 496
R. La Corte Italy 12 58 0.3× 214 1.3× 62 0.4× 69 0.6× 150 2.0× 22 478
B Snyers Belgium 14 87 0.5× 59 0.3× 569 3.6× 31 0.3× 82 1.1× 33 718

Countries citing papers authored by S. Pay

Since Specialization
Citations

This map shows the geographic impact of S. Pay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Pay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Pay more than expected).

Fields of papers citing papers by S. Pay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Pay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Pay. The network helps show where S. Pay may publish in the future.

Co-authorship network of co-authors of S. Pay

This figure shows the co-authorship network connecting the top 25 collaborators of S. Pay. A scholar is included among the top collaborators of S. Pay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Pay. S. Pay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pay, S., et al.. (2024). The effect of health insurance coverage on antenatal care utilization in Cambodia: A secondary analysis of Cambodia Demographic and Health Survey 2021–2022. SHILAP Revista de lepidopterología. 4(11). e0002954–e0002954. 1 indexed citations
2.
Yılmaz, Sedat, et al.. (2016). FRI0500 Idiopathic Granulomatous Mastitis: A Single Center Experience. Annals of the Rheumatic Diseases. 75. 619–619. 1 indexed citations
4.
Yılmaz, Sedat, et al.. (2014). THU0378 Tocilizumab in the Treatment of Patients with AA Amyloidosis Secondary to Familial Mediterranean Fever: CASE Series. Annals of the Rheumatic Diseases. 73. 312–313. 1 indexed citations
5.
Pay, S., Hakan Erdem, Uğur Muşabak, et al.. (2008). Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?. PubMed. 25(4 Suppl 45). S70–5. 27 indexed citations
6.
Pay, S., Uğur Muşabak, İsmail Şimşek, et al.. (2008). Synovial lymphoid neogenetic factors in Behçet's synovitis: do they play a role in self-limiting and subacute course of arthritis?. PubMed. 25(4 Suppl 45). S21–6. 5 indexed citations
7.
Erdem, Hatice Rana, et al.. (2007). Optic neuritis occurring with anti-tumour necrosis factor α therapy. Annals of the Rheumatic Diseases. 66(9). 1255–1258. 83 indexed citations
8.
Dinç, A, et al.. (2006). The proportional Venn diagram of Behçet's disease-related manifestations among young adult men in Turkey.. PubMed. 23(4 Suppl 38). S86–90. 1 indexed citations
9.
Erdem, Hakan, A Dinç, S. Pay, İsmail Şimşek, & Mustafa Turan. (2006). Peripheral insulin resistance in patients with Behçet's disease. Journal of the European Academy of Dermatology and Venereology. 20(4). 391–395. 18 indexed citations
10.
Bozoğlu, Ergün, A Dinç, Hakan Erdem, et al.. (2006). Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behçet's patients with venous thrombosis.. PubMed. 23(4 Suppl 38). S42–8. 34 indexed citations
11.
Pay, S., Uğur Muşabak, Hatice Rana Erdem, et al.. (2005). Chimerical Anti-TNF-α, Infliximab, Inhibits Neutrophil Chemotaxis and Production of Reactive Oxygen Species by Blocking the Priming Effect of Mononuclear Cells on Neutrophils. Immunopharmacology and Immunotoxicology. 27(2). 187–198. 14 indexed citations
12.
Muşabak, Uğur, S. Pay, Hakan Erdem, et al.. (2005). Serum interleukin-18 levels in patients with Behçet’s disease. Is its expression associated with disease activity or clinical presentations?. Rheumatology International. 26(6). 545–550. 59 indexed citations
13.
Yılmaz, Mahmut İlker, et al.. (2004). Antiannexin V autoantibody in thrombophilic Beh�et?s disease. Rheumatology International. 24(2). 77–79. 11 indexed citations
14.
Muşabak, Uğur, A. Şengül, Çağatay Öktenli, et al.. (2004). Does immune activation continue during an attack-free period in familial Mediterranean fever?. Clinical & Experimental Immunology. 138(3). 526–533. 46 indexed citations
16.
Dinç, A, et al.. (2001). Dermographism and atopy in patients with Behçet's disease.. PubMed. 10(6). 368–71. 5 indexed citations
17.
Pay, S., Meral Çalgünerı, Zafer Çalışkaner, et al.. (2000). Evaluation of vascular injury with proinflammatory cytokines, thrombomodulin and fibronectin in patients with primary fibromyalgia.. PubMed. 63(3-4). 115–22. 16 indexed citations
18.
Dinç, A, et al.. (2000). A Case of Churg-Strauss Syndrome Presenting with Cortical Blindness. Clinical Rheumatology. 19(4). 318–320. 15 indexed citations
19.
Dinç, A, et al.. (2000). A Case of Churg–Strauss Syndrome Presenting with Cortical Blindness. Clinical Rheumatology. 19(4). 318–318. 13 indexed citations
20.
Kiraz, Sedat, İhsan Ertenli, Mustafa Arıcı, et al.. (1999). Effects of colchicine on inflammatory cytokines and selectins in familial Mediterranean fever.. PubMed. 16(6). 721–4. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026